PainChek General Discussion, page-8914

@AlCp Nope. Way off. Abbey is foundation. They build software on top of Abbey making the accuracy of ML algorithms more efficient as clinical consultations increase. Over time the diagnosis will become increasingly accurate as more patients use it. The critical objective for PCK is to increase the number of beds which therefore increase consultations. Biomarkers are invasive and despite cost of doing blood analysis is getting cheaper, I don't think dementia sufferers would feel less pain when they see things injected into them. It might aggravate their pain